CovaSyn
All Articles
Agent Setup11 min readMay 22, 2026

Improve Claude's Chemical AI Capabilities — Drug Discovery, Biologics, ICH M7 via MCP

Claude Haiku 4.5 reaches 21 percent on the ICLR 2026 chemistry benchmark. Attach the CovaSyn MCP server and it jumps to 85 percent. Same model, no fine-tuning, no prompt magic — just deterministic chemistry tools wired through the Model Context Protocol. This is the practical guide: how to wire it, what it unlocks for drug discovery and biologics, and the limits to know.

OK

Oliver Kraft

CovaSyn

Improve Claude's Chemical AI Capabilities — Drug Discovery, Biologics, ICH M7 via MCP

Lead

Claude is the strongest LLM for chemistry agent workflows in May 2026, but only once you give it a chemistry tool layer. Out of the box, Claude Opus 4.7 hits 40.8 percent on the ICLR 2026 MolecularIQ benchmark; Claude Haiku 4.5 hits 21.2 percent. Wire either one to CovaSyn's chemical MCP tools and accuracy rises to 91.5 and 85.4 percent respectively, with the audit trail and reproducibility a pharma submission needs. This is the practical setup guide for Claude Desktop, Claude.ai connectors, and the Claude API.

What are chemical MCP tools?

Chemical MCP tools are deterministic cheminformatics functions — solubility prediction, ADMET profiling, ICH M7 mutagenic-impurity triage, mass spectrometry interpretation, NMR analysis, ICH Q1 stability kinetics — exposed to an LLM agent through the Model Context Protocol. The agent calls them like APIs, gets back validated, version-pinned results, and reasons over those results instead of guessing. The Model Context Protocol itself was specified by Anthropic in 2024 and is now jointly maintained by Anthropic, OpenAI, and major open-source projects as the industry standard for agent-tool integration.

In contrast, an untooled Claude has to compute logP from its training-data memory. That works for intuitive answers and fails for regulatory-grade ones. The Klambauer Lab benchmark proved it on 3,540 verified tasks. The detail is in the ICLR 2026 MolecularIQ benchmark write-up.

Why Claude matters for chemistry agents

Three reasons Claude has emerged as the agent runtime of choice for pharma R&D in 2026.

First, Bristol Myers Squibb deployed Claude across 30,000+ employees in May 2026, explicitly including R&D. The deal made Claude the de-facto pharma-enterprise LLM. Other Big Pharma will follow this pattern. CovaSyn is the chemistry tool layer that turns those rollouts into reproducible workflows, the gap that the BMS announcement does not close.

Second, Claude Desktop and Claude.ai support MCP servers natively. No bespoke plugin format, no Anthropic-specific tool API. The same MCP server runs identically in Claude, in Cursor, in your own agent. Less vendor lock-in than any competitor.

Third, the ICLR 2026 benchmark numbers. Three frontier LLMs, with and without CovaSyn MCP attached, on 3,540 symbolically verified chemistry tasks:

  • Claude Haiku 4.5: 21.18 percent baseline → 85.38 percent with CovaSyn (4.03× lift)
  • Claude Opus 4.7: 40.75 percent baseline → 91.51 percent with CovaSyn (2.25× lift)
  • OpenAI GPT-5.5: 22.29 percent baseline → 89.92 percent with CovaSyn (4.03× lift)

The lift is structural, not model-specific. It comes from the deterministic tool layer eliminating hallucination, not from anything Claude-specific. But Claude's tool-calling reliability and its connector model make this the easiest stack to deploy in a regulated environment today.

How CovaSyn connects chemistry to Claude

CovaSyn runs as an MCP server. Once registered with Claude, the agent sees 130 deterministic chemistry tools across 8 families: covabasic, covachem, covatox, covams, covnmr, covafold, covabio, covastab, covaopt, covadoe and supporting modules. The agent picks the right tool, calls it, gets back a structured response, and reasons over the result.

Concrete domain coverage:

  • Drug discovery — ADMET profile, druglikeness, scaffold analysis, BRICS fragmentation, similarity search, off-target tox screening
  • Biologics — antibody developability, peptide profiling, ADC linker design, mRNA design, oligo therapeutics, immunogenicity prediction, viscosity
  • Process development — design of experiments, response surface modeling, solvent selection, crystallization, scale-up kinetics
  • Regulatory — ICH M7 mutagenicity batch assessment, ICH Q1A/Q1E stability with Arrhenius fits, impurity profiling, ICH Q12 readiness

The tool layer is deterministic by construction: same input on call number 1,000 returns the same output as on call number 1. Every call is version-pinned and audit-logged. This is what makes the architecture viable for GAMP 5 Software Category 4 contexts.

A worked tool call, step by step

Concrete example. Someone asks Claude:

> "I have compound CN1CCN(CC1)c1ccc(cc1)C(=O)Nc1ccc(cc1)c1ccncc1. Run an ICH M7 mutagenicity assessment and give me the residual risk class."

Without tools, Claude pattern-matches against training data and produces a plausible-but-not-reproducible answer. With the CovaSyn MCP server attached, Claude routes this to the right tool:

{
  "tool": "covatox_assess_ichm7_batch",
  "arguments": {
    "smiles": ["CN1CCN(CC1)c1ccc(cc1)C(=O)Nc1ccc(cc1)c1ccncc1"],
    "include_expert_review": true
  }
}

The tool returns a structured response that the agent can summarise to the user and attach to an audit log:

{
  "results": [{
    "smiles": "CN1CCN(CC1)c1ccc(cc1)C(=O)Nc1ccc(cc1)c1ccncc1",
    "ich_m7_class": 5,
    "class_label": "No alert",
    "supporting_evidence": ["No structural alerts (Lhasa Nexus profile)", "No QSAR positive (Sarah Nexus + Derek)"],
    "qsar_engine_version": "sarah-3.2.1+derek-2024.2",
    "audit_id": "ct-2026-05-22-a1b2c3d4",
    "timestamp": "2026-05-22T11:03:42Z"
  }]
}

The same call from the same SMILES at 03:00 next Tuesday returns the same payload, byte-identical. That is the property an auditor checks.

Cost: cents per compound vs CRO pricing

A rough comparison for a 1,000-compound mutagenicity triage run, the kind a med-chem team does monthly during lead optimisation:

| Path | Time per compound | Cost per compound | Cost per 1,000 compounds | |---|---|---|---| | Manual CRO ICH M7 assessment | 2–5 days | €150–800 | €150,000–800,000 | | Claude Opus 4.7 (no tools) | ~3 seconds | €0.03 | €30 — but only 41% accurate | | Claude Opus 4.7 + CovaSyn MCP | ~5 seconds | €0.13 | €130 — 92% accurate, audit-logged | | Claude Haiku 4.5 + CovaSyn MCP | ~3 seconds | €0.008 | €8 — 85% accurate, audit-logged |

The Haiku-plus-MCP row is the one that changes the economics. More than 2× the accuracy of Opus baseline at one sixteenth of the cost, with a full audit trail. A new middle ground between cheap-and-wrong and expensive-and-correct, exactly the configuration that makes large screening campaigns financially viable.

Where this breaks down

Honest limitations. CovaSyn + Claude is not magic, and we publish the gaps.

  • Hard novel chemistry. If the target compound is well outside the training distribution of the underlying Q-SAR engines (rare ring systems, exotic heterocycles), the deterministic tool returns lower confidence. The agent reports the confidence, which is the right behaviour — but a human still has to decide whether to trust it.
  • Multi-step reasoning chains. Where the agent has to chain 5+ tool calls (e.g. full retrosynthesis), error compounds. Claude Opus is more reliable here than Haiku because its planning is stronger.
  • GxP validation is still your job. CovaSyn is GxP-aligned and produces audit-able outputs, but the validation of a specific use case at a specific customer site is a customer process. See our Trust & Compliance page for what we do and do not claim.

Getting started — Claude Desktop

The fastest path. Add CovaSyn to your claude_desktop_config.json:

{
  "mcpServers": {
    "covasyn": {
      "command": "npx",
      "args": ["-y", "@covasyn/mcp-client"],
      "env": {
        "COVASYN_API_KEY": "sk-cova-…"
      }
    }
  }
}

Restart Claude Desktop. The 130 CovaSyn tools appear in the connector panel. First chemistry question lands in seconds. Free tier gives you 100 credits per week, enough to evaluate end-to-end.

Getting started — Claude.ai web (OAuth)

Open Claude.ai → Settings → Connectors → Add Connector. Paste https://workspace.covasyn.com/mcp as the connector URL. The OAuth 2.1 + PKCE flow authenticates you against your CovaSyn account; no API key in browser. From the next conversation, Claude on the web can call CovaSyn tools.

Getting started — Claude API

For your own agent stack. The CovaSyn MCP server speaks the standard MCP protocol over stdio or HTTP, so any Claude-API agent that supports MCP can attach it:

```python from anthropic import Anthropic from mcp.client.stdio import stdio_client

client = Anthropic() async with stdio_client("npx", "-y", "@covasyn/mcp-client", env={"COVASYN_API_KEY": "sk-cova-…"}) as mcp: tools = await mcp.list_tools() response = client.messages.create( model="claude-opus-4-7", max_tokens=4096, tools=tools, messages=[{"role": "user", "content": "ICH M7 triage for compound X"}], ) ```

For Self-Hosted-Container deployments, replace the MCP-client invocation with a connection to your own CovaSyn instance. Setup is the same; the network path is internal.

FAQ

How is "AI for chemistry" different from "Claude for chemistry"?

AI for chemistry is the architecture: an LLM agent plus a deterministic tool layer. Claude for chemistry is one instance of that architecture, with Claude as the LLM. The deterministic layer is what makes the agent reproducible enough for pharma; the LLM choice is more about ergonomics, cost and developer comfort. See the AI for chemistry pillar page for the broader frame.

Does Claude need to be fine-tuned on chemistry to work well with CovaSyn?

No. The whole point of the MCP architecture is that Claude does not need chemistry-specific training. It reasons, plans and orchestrates; CovaSyn computes. The ICLR 2026 benchmark numbers are with stock Claude, no fine-tuning.

Is the CovaSyn output deterministic at temperature 0 on Claude's side?

The CovaSyn tool output is deterministic regardless of LLM temperature — same input always returns same output, with the same version-pinned engines. Claude's surrounding text may vary, but the numerical chemistry answers don't.

What about Claude in regulated EU pharma environments?

Claude itself is hosted by Anthropic (US, with EU regions in roll-out 2026). CovaSyn is hosted in Germany (Hetzner Leipzig) for DACH data residency, with a self-hosted container option for IT-Security setups that exclude any external hosting. See the security posture for details.

What if my team doesn't use Claude — does this still apply?

Yes. The same CovaSyn MCP server works with Gemini (Gemini guide), ChatGPT (ChatGPT guide), Cursor and open-weight models like DeepSeek or Qwen (Cursor & open-weights guide). MCP is the standard, vendor-neutral.

Sources

CovaSyn MCP

Scientific tools in your AI workflow.

130+ functions for pharma, biotech and chemistry. Free tier instantly active.

Improve Claude's Chemical AI Capabilities — Drug Discovery, Biologics, ICH M7 via MCP | CovaSyn